Biohaven (NYSE:BHVN) stock gains as the FDA cancels an advisory meeting scheduled to review its marketing application for ...

The latest announcement is out from Biohaven Ltd. ( (BHVN) ).

Biohaven Ltd. (NYSE:BHVN) stock is trading higher on Friday following an update with respect to its New Drug Application for ...

Levi & Korsinsky, LLP notifies investors in Biohaven Ltd. ("Biohaven Ltd." or the "Company") (NYSE: BHVN) of a class action securities lawsuit.

On a very good Friday for the stock market, Biohaven 's (NYSE: BHVN) performance was exceptional. The clinical-stage biotech 's share price inflated by over 6% that trading session thanks to ...

Investing.com -- Biohaven Ltd. (NYSE: BHVN) stock rose 3% Friday morning after the company announced that the U.S. Food and Drug Administration (FDA) no longer plans to hold an advisory committee ...

Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...

Analysts found the agency's decision to cancel the meeting encouraging. Elsewhere, the Novo Holdings-owned CDMO cut about 350 ...

Stock futures ticked higher on Friday as investors awaited Federal Reserve Chair Jerome Powell’s speech at Jackson Hole, looking for clues on the outlook for mo ...